Drugs that target SLC transporters
The global market for Drugs Targeting SLC Transporters was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs Targeting SLC Transporters, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drugs Targeting SLC Transporters by region & country, by Type, and by Application.
The Drugs Targeting SLC Transporters market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Targeting SLC Transporters.
Market Segmentation
By Company
Jnana Therapeutics
Merck
Janssen Pharmaceuticals
AstraZeneca
Hengrui
Johnson & Johnson
Kelun Pharmaceutical
Zhengda Tianqing
Hansoh Pharmaceuticals
Orifarm
Starpharma
Sandoz
Bristol-Myers Squibb
Boehringer Ingelheim
Segment by Type:
Diuretics
Antidepressants
SGLT-2 Inhibitors
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drugs Targeting SLC Transporters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drugs Targeting SLC Transporters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drugs Targeting SLC Transporters in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Drugs Targeting SLC Transporters Product Introduction
1.2 Global Drugs Targeting SLC Transporters Market Size Forecast
1.2.1 Global Drugs Targeting SLC Transporters Sales Value (2019-2030)
1.2.2 Global Drugs Targeting SLC Transporters Sales Volume (2019-2030)
1.2.3 Global Drugs Targeting SLC Transporters Sales Price (2019-2030)
1.3 Drugs Targeting SLC Transporters Market Trends & Drivers
1.3.1 Drugs Targeting SLC Transporters Industry Trends
1.3.2 Drugs Targeting SLC Transporters Market Drivers & Opportunity
1.3.3 Drugs Targeting SLC Transporters Market Challenges
1.3.4 Drugs Targeting SLC Transporters Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drugs Targeting SLC Transporters Players Revenue Ranking (2023)
2.2 Global Drugs Targeting SLC Transporters Revenue by Company (2019-2024)
2.3 Global Drugs Targeting SLC Transporters Players Sales Volume Ranking (2023)
2.4 Global Drugs Targeting SLC Transporters Sales Volume by Company Players (2019-2024)
2.5 Global Drugs Targeting SLC Transporters Average Price by Company (2019-2024)
2.6 Key Manufacturers Drugs Targeting SLC Transporters Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Drugs Targeting SLC Transporters Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drugs Targeting SLC Transporters
2.9 Drugs Targeting SLC Transporters Market Competitive Analysis
2.9.1 Drugs Targeting SLC Transporters Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Drugs Targeting SLC Transporters Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Targeting SLC Transporters as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diuretics
3.1.2 Antidepressants
3.1.3 SGLT-2 Inhibitors
3.2 Global Drugs Targeting SLC Transporters Sales Value by Type
3.2.1 Global Drugs Targeting SLC Transporters Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drugs Targeting SLC Transporters Sales Value, by Type (2019-2030)
3.2.3 Global Drugs Targeting SLC Transporters Sales Value, by Type (%) (2019-2030)
3.3 Global Drugs Targeting SLC Transporters Sales Volume by Type
3.3.1 Global Drugs Targeting SLC Transporters Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Drugs Targeting SLC Transporters Sales Volume, by Type (2019-2030)
3.3.3 Global Drugs Targeting SLC Transporters Sales Volume, by Type (%) (2019-2030)
3.4 Global Drugs Targeting SLC Transporters Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Drugs Targeting SLC Transporters Sales Value by Application
4.2.1 Global Drugs Targeting SLC Transporters Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drugs Targeting SLC Transporters Sales Value, by Application (2019-2030)
4.2.3 Global Drugs Targeting SLC Transporters Sales Value, by Application (%) (2019-2030)
4.3 Global Drugs Targeting SLC Transporters Sales Volume by Application
4.3.1 Global Drugs Targeting SLC Transporters Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Drugs Targeting SLC Transporters Sales Volume, by Application (2019-2030)
4.3.3 Global Drugs Targeting SLC Transporters Sales Volume, by Application (%) (2019-2030)
4.4 Global Drugs Targeting SLC Transporters Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Drugs Targeting SLC Transporters Sales Value by Region
5.1.1 Global Drugs Targeting SLC Transporters Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drugs Targeting SLC Transporters Sales Value by Region (2019-2024)
5.1.3 Global Drugs Targeting SLC Transporters Sales Value by Region (2025-2030)
5.1.4 Global Drugs Targeting SLC Transporters Sales Value by Region (%), (2019-2030)
5.2 Global Drugs Targeting SLC Transporters Sales Volume by Region
5.2.1 Global Drugs Targeting SLC Transporters Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Drugs Targeting SLC Transporters Sales Volume by Region (2019-2024)
5.2.3 Global Drugs Targeting SLC Transporters Sales Volume by Region (2025-2030)
5.2.4 Global Drugs Targeting SLC Transporters Sales Volume by Region (%), (2019-2030)
5.3 Global Drugs Targeting SLC Transporters Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Drugs Targeting SLC Transporters Sales Value, 2019-2030
5.4.2 North America Drugs Targeting SLC Transporters Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Drugs Targeting SLC Transporters Sales Value, 2019-2030
5.5.2 Europe Drugs Targeting SLC Transporters Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Drugs Targeting SLC Transporters Sales Value, 2019-2030
5.6.2 Asia Pacific Drugs Targeting SLC Transporters Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Drugs Targeting SLC Transporters Sales Value, 2019-2030
5.7.2 South America Drugs Targeting SLC Transporters Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drugs Targeting SLC Transporters Sales Value, 2019-2030
5.8.2 Middle East & Africa Drugs Targeting SLC Transporters Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drugs Targeting SLC Transporters Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drugs Targeting SLC Transporters Sales Value
6.2.1 Key Countries/Regions Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.2.2 Key Countries/Regions Drugs Targeting SLC Transporters Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.3.2 United States Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.4.2 Europe Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.5.2 China Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.6.2 Japan Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.7.2 South Korea Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.8.2 Southeast Asia Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drugs Targeting SLC Transporters Sales Value, 2019-2030
6.9.2 India Drugs Targeting SLC Transporters Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drugs Targeting SLC Transporters Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Jnana Therapeutics
7.1.1 Jnana Therapeutics Company Information
7.1.2 Jnana Therapeutics Introduction and Business Overview
7.1.3 Jnana Therapeutics Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Jnana Therapeutics Drugs Targeting SLC Transporters Product Offerings
7.1.5 Jnana Therapeutics Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Drugs Targeting SLC Transporters Product Offerings
7.2.5 Merck Recent Development
7.3 Janssen Pharmaceuticals
7.3.1 Janssen Pharmaceuticals Company Information
7.3.2 Janssen Pharmaceuticals Introduction and Business Overview
7.3.3 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Product Offerings
7.3.5 Janssen Pharmaceuticals Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca Drugs Targeting SLC Transporters Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Hengrui
7.5.1 Hengrui Company Information
7.5.2 Hengrui Introduction and Business Overview
7.5.3 Hengrui Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hengrui Drugs Targeting SLC Transporters Product Offerings
7.5.5 Hengrui Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Introduction and Business Overview
7.6.3 Johnson & Johnson Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Johnson & Johnson Drugs Targeting SLC Transporters Product Offerings
7.6.5 Johnson & Johnson Recent Development
7.7 Kelun Pharmaceutical
7.7.1 Kelun Pharmaceutical Company Information
7.7.2 Kelun Pharmaceutical Introduction and Business Overview
7.7.3 Kelun Pharmaceutical Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Kelun Pharmaceutical Drugs Targeting SLC Transporters Product Offerings
7.7.5 Kelun Pharmaceutical Recent Development
7.8 Zhengda Tianqing
7.8.1 Zhengda Tianqing Company Information
7.8.2 Zhengda Tianqing Introduction and Business Overview
7.8.3 Zhengda Tianqing Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zhengda Tianqing Drugs Targeting SLC Transporters Product Offerings
7.8.5 Zhengda Tianqing Recent Development
7.9 Hansoh Pharmaceuticals
7.9.1 Hansoh Pharmaceuticals Company Information
7.9.2 Hansoh Pharmaceuticals Introduction and Business Overview
7.9.3 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Product Offerings
7.9.5 Hansoh Pharmaceuticals Recent Development
7.10 Orifarm
7.10.1 Orifarm Company Information
7.10.2 Orifarm Introduction and Business Overview
7.10.3 Orifarm Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Orifarm Drugs Targeting SLC Transporters Product Offerings
7.10.5 Orifarm Recent Development
7.11 Starpharma
7.11.1 Starpharma Company Information
7.11.2 Starpharma Introduction and Business Overview
7.11.3 Starpharma Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Starpharma Drugs Targeting SLC Transporters Product Offerings
7.11.5 Starpharma Recent Development
7.12 Sandoz
7.12.1 Sandoz Company Information
7.12.2 Sandoz Introduction and Business Overview
7.12.3 Sandoz Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sandoz Drugs Targeting SLC Transporters Product Offerings
7.12.5 Sandoz Recent Development
7.13 Bristol-Myers Squibb
7.13.1 Bristol-Myers Squibb Company Information
7.13.2 Bristol-Myers Squibb Introduction and Business Overview
7.13.3 Bristol-Myers Squibb Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Bristol-Myers Squibb Drugs Targeting SLC Transporters Product Offerings
7.13.5 Bristol-Myers Squibb Recent Development
7.14 Boehringer Ingelheim
7.14.1 Boehringer Ingelheim Company Information
7.14.2 Boehringer Ingelheim Introduction and Business Overview
7.14.3 Boehringer Ingelheim Drugs Targeting SLC Transporters Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Boehringer Ingelheim Drugs Targeting SLC Transporters Product Offerings
7.14.5 Boehringer Ingelheim Recent Development
8 Industry Chain Analysis
8.1 Drugs Targeting SLC Transporters Industrial Chain
8.2 Drugs Targeting SLC Transporters Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drugs Targeting SLC Transporters Sales Model
8.5.2 Sales Channel
8.5.3 Drugs Targeting SLC Transporters Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Jnana Therapeutics
Merck
Janssen Pharmaceuticals
AstraZeneca
Hengrui
Johnson & Johnson
Kelun Pharmaceutical
Zhengda Tianqing
Hansoh Pharmaceuticals
Orifarm
Starpharma
Sandoz
Bristol-Myers Squibb
Boehringer Ingelheim
听
听
*If Applicable.